Complete Blood Count (CBC)
Measures red cells, white cells—including lymphocytes—and platelets. Low counts can suggest bone marrow involvement; high lymphocytes occur in some subtypes. Many people with lymphoma have a normal CBC.
Diagnostic-first blood test guide
Lymphoma Blood Test: What Blood Work Reveals and What Screening Adds
Blood work can reveal clues, but only a tissue biopsy can diagnose lymphoma. Learn what CBC and LDH results mean before considering the separate question of multi-cancer screening.
Start with the diagnostic answerClinical review status
Pending physician review. A named MD has not yet been supplied; no medical reviewer is represented in the page schema.
The diagnostic answer first
Can a Blood Test Detect Lymphoma?
Blood tests can reveal signs that lymphoma may be present—including abnormal complete blood count (CBC) results or elevated lactate dehydrogenase (LDH)—but blood tests alone cannot diagnose lymphoma. A definitive diagnosis requires a biopsy of a lymph node or affected tissue.
Separately, Galleri® is a multi-cancer blood test for people without symptoms. It screens for a DNA signal shared by more than 50 cancer types, lymphoma among them. It is screening, not diagnosis, is not lymphoma-specific, and is under FDA review.
If you have unexplained swollen lymph nodes, night sweats, unexplained weight loss, fever or persistent fatigue, seek clinical evaluation rather than relying on screening. See cancers the Galleri test screens for.
Supportive—not definitive
Blood Tests Used in Lymphoma Workup
When doctors suspect lymphoma, they commonly order a CBC, LDH, blood chemistry and infection screening. Each provides different information about health and possible disease extent.
Lactate Dehydrogenase (LDH)
LDH can rise with greater cell turnover, tumor burden or aggressive disease. It is nonspecific and can also rise with exercise, hemolysis, liver disease or infection.
Blood Chemistry and Organ Function
Liver and kidney function, electrolytes, beta-2 microglobulin and sometimes ESR or CRP help assess overall health, organ effects and a baseline before treatment.
Infection Screening
HIV, hepatitis B and hepatitis C testing can influence treatment. EBV, CMV or H. pylori testing may be relevant in selected subtypes.
Flow Cytometry and Immunophenotyping
Can identify circulating abnormal cells and B-cell or T-cell origin when lymphoma reaches the bloodstream. It is not always part of initial workup and does not replace tissue biopsy.
Reassuring—but not an all-clear
What Normal Blood Test Results Mean
Normal blood test results do not rule out lymphoma. Many people diagnosed with lymphoma had normal CBC and LDH results at diagnosis. Blood work helps assess overall health and disease extent; “normal” is not the same as “no lymphoma.”
Symptoms still matter
If blood work is normal but unexplained swollen nodes, night sweats, weight loss, fever or persistent fatigue continue, ask your doctor what further evaluation is appropriate.
Tissue provides the answer
How Lymphoma Is Actually Diagnosed
Lymphoma is diagnosed through a biopsy: part or all of a swollen lymph node or affected tissue is examined under a microscope. Blood tests and imaging help guide and stage the workup, but do not replace tissue.
An excisional biopsy removes a whole node; an incisional biopsy removes part of it. A core-needle biopsy may be used in selected locations, though a larger tissue sample is often needed to classify Hodgkin or non-Hodgkin lymphoma.
CT, PET-CT and MRI map possible disease. Bone marrow aspiration/biopsy and lumbar puncture are used when indicated. Immunohistochemistry, flow cytometry, FISH and PCR on biopsy tissue help identify subtype and guide care.
A separate screening question
Can You Screen for Lymphoma Before Symptoms?
There is no routine lymphoma screening test for average-risk adults. No medical guideline recommends regular lymphoma screening in the way mammography or colonoscopy is used for other cancers.
Galleri uses one blood draw to analyze methylation patterns in cell-free DNA and usually returns results in about two weeks. It screens for a signal shared by more than 50 cancer types, including lymphoma, but was not designed or validated as a lymphoma-specific test.
No guideline body recommends Galleri. It is under FDA review. A signal requires diagnostic workup and, for suspected lymphoma, tissue biopsy. Review is Galleri FDA-approved? and whether the Galleri test is worth it for you.
Study design changes the answer
How Accurate Is Galleri for Lymphoma?
Lymphoma is in GRAIL’s pre-specified group of 12. In CCGA3, a case-control study of people already known to have cancer, Galleri found 56.3% of lymphomas. Case-control designs can overstate real-world performance.
| Stage | Sensitivity | N (Klein et al.) |
|---|---|---|
| I | 27.3% | 9/33 |
| II | 58.3% | 28/48 |
| III | 71.7% | 33/46 |
| IV | 60.9% | 28/46 |
| All stages | 56.3% (case-control) | 98/174 |
Every figure in this table is case-control and secondary-sourced from Klein et al. (2021); verify against Figure 3 before publishing. Stage III exceeding Stage IV is unusual and may reflect tumor biology and differing cfDNA shedding—not a predictable progression pattern.
In prospective PATHFINDER 2 full results (35,878 adults, May 2026), sensitivity was 69.8% for all 12 pre-specified cancers together, 39.3% across all cancers, specificity 99.6%, PPV 60.3% and overall Cancer Signal Origin accuracy 91.3%. These are not lymphoma-only results. Interim ESMO 2025 results were 73.7% and 40.4%.
A secondary-sourced ASH 2023 abstract reported 70.5% case-control sensitivity for DLBCL and 95.2–99% Cancer Signal Origin accuracy for lymphoid lineage. These figures require primary-source verification and suggest—but do not establish—that aggressive and indolent subtypes may shed different amounts of cfDNA.
NHS-Galleri results were mixed: the primary endpoint was not met, while Stage IV diagnoses fell by more than 20% in rounds two and three.
Bottom line: in the case-control study, Galleri found a little over half of lymphomas. A prospective lymphoma-only figure has not been verified. A “No Cancer Signal Detected” result does not rule out lymphoma.
Different jobs
Diagnostic Blood Tests vs Screening Blood Test
CBC, LDH and flow cytometry support evaluation when lymphoma is suspected. Galleri is used in people without symptoms to screen for a shared multi-cancer signal. None diagnoses lymphoma.
| Feature | CBC | LDH | Flow cytometry | Galleri |
|---|---|---|---|---|
| Purpose | Diagnostic / monitoring | Diagnostic / prognostic | Diagnostic | Screening |
| When used | Symptoms or suspected lymphoma | Symptoms present | Suspected blood-borne lymphoma | Asymptomatic adults (50+ or elevated risk) |
| What it measures | Blood cell counts | Enzyme from damaged cells | Cell-surface proteins (B/T-cell) | cfDNA methylation patterns |
| Can diagnose lymphoma? | No | No | Helps characterize; does not diagnose | No—screens for a signal |
| Lymphoma sensitivity | Variable; many lymphomas have normal CBC | Elevated in about half of NHL | High when lymphoma is circulating | 56.3% (case-control, CCGA3; not prospective) |
| Screens for other cancers? | No | No; nonspecific | No | Yes—a signal shared by 50+ cancer types |
| FDA status | Standard of care | Standard of care | Standard of care | Under FDA review; no decision |
| Cost | Generally insurance-covered when indicated | Generally insurance-covered when indicated | Generally insurance-covered when indicated | $798 through HLI; not covered by Medicare |
| Requires | Doctor’s order | Doctor’s order | Hematologist’s order | Doctor’s order |
The 56.3% figure is case-control and is not a prospective screening estimate. Galleri does not replace a clinical lymphoma workup.
Eligibility and guardrails
Who Should Consider Lymphoma Screening?
Because no routine lymphoma screening exists, most people are diagnosed after symptoms or an incidental finding. Galleri is one optional multi-cancer screen—not a standalone lymphoma screen.
Know what raises risk
Age, immunosuppression, some autoimmune conditions, family history and certain prior infections can raise lymphoma risk. These factors do not create a standard screening schedule.
Elevated cancer risk
Galleri is physician-ordered and recommended for adults at elevated cancer risk, such as those 50 or older. It is not recommended during pregnancy, at age 21 or younger, or during active cancer treatment.
Evaluate—do not screen
Swollen nodes, night sweats, fever, weight loss or persistent fatigue need medical evaluation. Galleri is not a replacement for blood work, imaging or biopsy.
Whole genome sequencing cannot detect an existing lymphoma and rarely changes lymphoma screening because no routine screening pathway exists. For a strong family history, see what the $599 genome service includes.
Related diagnostic guides for a multiple myeloma blood test and leukemia blood test are planned. These conditions and their workups should not be treated as interchangeable. For now, use the cancer guide hub.
Clear answers
FAQ
Will lymphoma show up on a blood test?
Diagnostic blood tests such as a CBC or LDH may show signs consistent with lymphoma, but they cannot diagnose it. Many people with lymphoma have completely normal blood work. Diagnosis requires a tissue biopsy.
What blood count is high with lymphoma?
Lymphocyte counts may be elevated in some subtypes, particularly chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Infections can also raise lymphocytes, so an elevated count alone is not diagnostic.
Can Galleri detect lymphoma?
Galleri screens for a DNA signal shared by more than 50 cancer types, including lymphoma. In a case-control study it detected 56.3% of lymphomas; a prospective lymphoma-only figure has not been verified. It is not lymphoma-specific and is under FDA review.
Is there a screening test for lymphoma?
There is no routine screening test recommended specifically for lymphoma. Galleri is a multi-cancer early detection test that includes lymphoma among more than 50 cancer types, but it was not designed as a lymphoma-specific screen and no guideline body recommends it.
What does elevated LDH mean?
LDH is an enzyme released by damaged cells. Elevated LDH can occur with lymphoma, but also with exercise, hemolysis, liver disease and infections. It is a nonspecific marker.
Sources and Evidence Notes
Key sources: American Cancer Society, Tests for Non-Hodgkin Lymphoma; NCI Adult Non-Hodgkin Lymphoma PDQ; NCCN B-Cell Lymphomas Guidelines; Klein et al., Annals of Oncology (2021, CCGA case-control); Westgate et al., Blood ASH abstract (2023, case-control); GRAIL PATHFINDER 2 releases (October 2025 and May 2026); GRAIL NHS-Galleri release (2026); Galleri HCP performance page; and FDA advisory committee materials (September 2026). Unverified secondary-sourced subtype and stage figures are labeled. Study percentages describe populations, not one person.